Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

LiteVax B.V.
Sponsor

LiteVax B.V.

The Netherlands Akkersestraat 50, 4061 BJ, The Netherlands

About the sponsor

LiteVax B.V. conducts clinical research in influenza vaccine development, with attention to safety, tolerability, and immunogenicity in healthy adults across different age groups.

  • Adjuvanted influenza vaccines
  • Healthy adult immunisation
  • Age-related immune responses

The sponsor’s influenza programme includes interest in vaccine formulations designed to enhance immune responses while maintaining acceptable tolerability.

About Specializations

LiteVax B.V. runs clinical trials in conditions such as Influenza, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Influenza

Not recruiting

A Study to Test the Safety and Body's Response to TETRALITE Influenza Vaccine Compared to Vaxigrip Tetra Vaccine in Healthy Adults Aged 18 to 50 Years

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Substances:A/Victoria/2570/2019 (H1N1)Pdm09-Like Strain (A/Victoria/2570/2019, Ivr-215)
  • Sponsor:LiteVax B.V.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.